Sg3 Management, LLC Eli Lilly & CO Put Options Transaction History

Sg3 Management, LLC

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $576,160 - $709,046	-2,600 Reduced 8.36%	28,500 $6.59 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $2.27 Million - $2.94 Million	12,600 Added 68.11%	31,100 $7.14 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $3.04 Million - $3.94 Million	18,500 New	18,500 $3.46 Million
Q2 2019 Aug 09, 2019	SELL	$110.79 - $129.32 $19.4 Million - $22.6 Million	-175,000 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$111.31 - $131.02 $19.5 Million - $22.9 Million	175,000 New	175,000 $22.7 Million

4,007

752M

8.27M

10.5M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.